Mesalamine 400mg (Novo-5-ASA)
Mesalamine 400mg (Novo-5-ASA)
$67.42
Earn 3 points upon purchasing this product.
100 Tablets
Requires Prescription
SKU: 21283 Categories: Anti Inflammatory Drugs, Asacol, Canada, Generic, Prescription DrugsMesalamine
Uses of Mesalamine
Administer Mesalamine to provide medical aid for people who experience ulcerative colitis. It is marketed under the generic name Mesalazine. This medicine is also used in preventing ulcerative colitis from happening again. It is suitable for adults and children age 5 years old.
Besides Mesalamine, Mesalazine is also available under the trade names Asacol, Lialda, and Pentasa.
Mesalamine Precautions and Warnings
Stop consuming this medicine if you experience the following:
- Severe stomach pain
- Stomach cramping
- Bloody diarrhea
- Skin rashes
- Severe headache
Aside from the mentioned reactions, always tell your medical professional if you have the following:
- Kidney stone
- Kidney disease
- Liver disease
- Pyloric stenosis
- Eczema
Mesalamine Dosage
Oral dosage for Mesalamine
- 250 – 500 mg capsules of Mesalamine
- The required dosage is 3-4 times medicine consumption in a day
- The duration of therapy is 6-8 weeks, depending on the intensity of treatment.
Mesalamine Side Effects
Learn the different side effects of consuming Mesalamine. These side effects may include:
Common Side Effects of Mesalamine
- Nausea
- Constipation
- Vomiting
- Stomach pain
- Diarrhea
- Dizziness
- Sore throat
- Sneezing
- Back pain
- headache
Severe Side Effects of Mesalamine
- Severe stomach pain
- Severe headache
- Redness of the eyes
- Bloody stools
- Skin sores
- Lightheadedness
- Trouble breathing
- Kidney problems
- Liver problems
Only logged in customers who have purchased this product may leave a review.
Cart
Product Search
Product Categories
Top Rated Products
-
Cymbalta 60mg
$142.55
-
Diovan HCT 320/12.5mg
$65.67
-
Edarbyclor 40/12.5mg
$55.99
-
Estradot (Vivelle Dot) 25ug
$43.41
-
Flovent HFA 50mcg
$53.69
-
Janumet XR 100/1000mg
$125.99
Reviews
There are no reviews yet.